From: The vascular access questionnaire: a single centre UK experience
Total N | VAQ Score | ||||
---|---|---|---|---|---|
N (%) | Mean | Median (IQR) | p-Value | ||
Age (Years) | 749 | <0.001* | |||
<55 | 175 (23.4%) | 7.7 | 6 (2–11) | ||
55–64 | 183 (24.4%) | 6.2 | 4 (1–8) | ||
65–74 | 178 (23.8%) | 4.9 | 3 (1–7) | ||
75+ | 213 (28.4%) | 3.8 | 3 (1–6) | ||
Gender | 749 | <0.001 | |||
Female | 316 (42.2%) | 6.7 | 5 (2–10) | ||
Male | 433 (57.8%) | 4.7 | 3 (1–7) | ||
Ethnicity | 748 | <0.001 | |||
White | 369 (49.3%) | 5.5 | 4 (2–8) | ||
Asian | 252 (33.7%) | 5.2 | 3 (0–7) | ||
Black | 124 (16.6%) | 6.4 | 5 (2–10) | ||
Mixed | 3 (0.4%) | 4.7 | 3 (3–8) | ||
Peripheral Vascular Disease | 749 | 0.011 | |||
No | 641 (85.6%) | 5.3 | 3 (1–8) | ||
Yes | 108 (14.4%) | 7.2 | 5 (2–10) | ||
Cardiac disease | 749 | 0.055 | |||
No | 503 (67.2%) | 5.2 | 3 (1–7) | ||
Yes | 246 (32.8%) | 6.2 | 4 (1–9) | ||
Diabetes | 749 | 0.195 | |||
No | 450 (60.1%) | 5.8 | 4 (1–9) | ||
Diet Controlled | 66 (8.8%) | 4.2 | 3 (1–6) | ||
Tablet Controlled | 42 (5.6%) | 4.0 | 3 (0–7) | ||
Insulin | 191 (25.5%) | 5.8 | 4 (1–8) | ||
Unit | 749 | <0.001 | |||
Unit 1 | 43 (5.7%) | 3.6 | 2 (0–4) | ||
Unit 2 | 90 (12.0%) | 4.5 | 3 (1–7) | ||
Unit 3 | 116 (15.5%) | 4.6 | 3 (0–7) | ||
Unit 4 | 68 (9.1%) | 5.1 | 4 (2–8) | ||
Unit 5 | 79 (10.5%) | 5.3 | 3 (1–7) | ||
Unit 6 | 72 (9.6%) | 5.3 | 3 (1–7) | ||
Unit 7 | 96 (12.8%) | 6.1 | 5 (2–8) | ||
Unit 8 | 75 (10.0%) | 6.3 | 4 (1–9) | ||
Unit 9 | 56 (7.5%) | 7.8 | 7 (2–12) | ||
Unit 10 | 54 (7.2%) | 7.6 | 7 (4–12) | ||
Years of Haemodiaysis | 748 | 0.235* | |||
<2 | 188 (25.1%) | 5.1 | 3 (1–8) | ||
2–3 | 197 (26.3%) | 5.2 | 3 (1–7) | ||
4–7 | 188 (25.1%) | 6.0 | 4 (2–9) | ||
8+ | 175 (23.4%) | 5.7 | 4 (1–8) |